Lives lost to opioid toxicity among Ontarians who worked in the construction industry
This new report from the ODPRN, the Office of the Chief Coroner for Ontario/Ontario Forensic Pathology Service (OCC/OFPS) and Public Health Ontario (PHO), provides information on the disproportionate impact of opioid toxicity deaths among people working in the construction industry in Ontario.
COVID-19 Ontario Prescription Drug Utilization Tool: Update
This tool provides public access to interactive data on drug utilization in Ontario during the COVID-19 pandemic. This update includes data up to February 2022 (opioids, benzodiazepines, and stimulants up to December 2021).
Impact of a publicly funded pharmacy-dispensed naloxone program on fatal opioid overdose rates: A population-based study
This study examined the impact of the publicly funded Ontario Naloxone Program for Pharmacies (ONPP), implemented in June 2016, on provincial rates of opioid overdose deaths.
Impact of the COVID-19 pandemic on the prevalence of opioid agonist therapy discontinuation in Ontario, Canada: A population-based time series analysis
This study investigated the impact of the pandemic and the associated changes in OAT guidance on treatment discontinuation.